{
    "2020-04-29": [
        [
            {
                "time": "",
                "original_text": "这些股4月获北上资金净买入超10亿元",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "4月"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "IPO动态 | 康希诺频频融资未见产品上市，竞争力存疑未来三年难扭亏",
                "features": {
                    "keywords": [
                        "康希诺",
                        "融资",
                        "竞争力",
                        "扭亏"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北上资金这个胡汉三又杀回来了 逾500亿抄底净买入白酒双雄超80亿",
                "features": {
                    "keywords": [
                        "北上资金",
                        "抄底",
                        "白酒",
                        "净买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北上资金这个胡汉三又杀回来了：逾500亿抄底、净买入白酒双雄超80亿、增仓这家钛白粉公司超10倍！",
                "features": {
                    "keywords": [
                        "北上资金",
                        "抄底",
                        "白酒",
                        "钛白粉",
                        "增仓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "宝盈一季度调仓观察：消费、医药、科技各有所爱",
                "features": {
                    "keywords": [
                        "宝盈",
                        "调仓",
                        "消费",
                        "医药",
                        "科技"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "股价创新高与业绩遭“双杀” 机构和高管趁机减持华兰生物 盈利能力下降",
                "features": {
                    "keywords": [
                        "股价",
                        "创新高",
                        "业绩",
                        "双杀",
                        "减持",
                        "华兰生物",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[国信医药】疫情带动下，检测板块迎来业绩和估值的双击（周观点）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "疫情",
                        "检测板块",
                        "业绩",
                        "估值",
                        "双击"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[国元医药|点评】昭衍新药2020半年报点评：Q2保持高速增长态势，全年有望维持高景气",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "半年报",
                        "Q2",
                        "高增长",
                        "高景气"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "多只疫苗龙头一季度业绩不及预期 机构称疫情有望打开疫苗市场天花板 盈利能力下降",
                "features": {
                    "keywords": [
                        "疫苗",
                        "龙头",
                        "业绩",
                        "不及预期",
                        "疫情",
                        "市场天花板",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "分拆上市又要火！10余家上市公司密集公布分拆子公司创业板上市计划，有何影响？",
                "features": {
                    "keywords": [
                        "分拆上市",
                        "创业板",
                        "计划",
                        "影响"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "全球新冠疫苗竞速白热化：机构重金投入",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "竞速",
                        "白热化",
                        "机构",
                        "重金投入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "全球新冠疫苗竞速白热化：五类技术齐发，机构重金投入",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "竞速",
                        "白热化",
                        "五类技术",
                        "机构",
                        "重金投入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}